West Pharmaceutical Services SG&A Expenses 2010-2023 | WST

West Pharmaceutical Services annual/quarterly sg&a expenses history and growth rate from 2010 to 2023. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
  • West Pharmaceutical Services sg&a expenses for the quarter ending December 31, 2023 were $0.090B, a 5.02% increase year-over-year.
  • West Pharmaceutical Services sg&a expenses for the twelve months ending December 31, 2023 were $0.353B, a 11.52% increase year-over-year.
  • West Pharmaceutical Services annual sg&a expenses for 2023 were $0.353B, a 11.52% increase from 2022.
  • West Pharmaceutical Services annual sg&a expenses for 2022 were $0.317B, a 12.65% decline from 2021.
  • West Pharmaceutical Services annual sg&a expenses for 2021 were $0.363B, a 20.13% increase from 2020.
West Pharmaceutical Services Annual SG&A Expenses
(Millions of US $)
2023 $353
2022 $317
2021 $363
2020 $302
2019 $273
2018 $263
2017 $246
2016 $240
2015 $233
2014 $229
2013 $235
2012 $218
2011 $191
2010 $188
2009 $178
West Pharmaceutical Services Quarterly SG&A Expenses
(Millions of US $)
2023-12-31 $90
2023-09-30 $89
2023-06-30 $88
2023-03-31 $86
2022-12-31 $86
2022-09-30 $66
2022-06-30 $82
2022-03-31 $83
2021-12-31 $98
2021-09-30 $92
2021-06-30 $93
2021-03-31 $80
2020-12-31 $76
2020-09-30 $76
2020-06-30 $78
2020-03-31 $72
2019-12-31 $69
2019-09-30 $65
2019-06-30 $70
2019-03-31 $69
2018-12-31 $60
2018-09-30 $65
2018-06-30 $70
2018-03-31 $68
2017-12-31 $60
2017-09-30 $63
2017-06-30 $61
2017-03-31 $63
2016-12-31 $61
2016-09-30 $58
2016-06-30 $63
2016-03-31 $58
2015-12-31 $62
2015-09-30 $55
2015-06-30 $61
2015-03-31 $55
2014-12-31 $59
2014-09-30 $56
2014-06-30 $58
2014-03-31 $56
2013-12-31 $60
2013-09-30 $56
2013-06-30 $60
2013-03-31 $59
2012-12-31 $59
2012-09-30 $54
2012-06-30 $54
2012-03-31 $51
2011-12-31 $48
2011-09-30 $46
2011-06-30 $46
2011-03-31 $51
2010-12-31 $50
2010-09-30 $45
2010-06-30 $46
2010-03-31 $47
2009-12-31 $45
2009-09-30 $44
2009-06-30 $45
2009-03-31 $43
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $26.529B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $72.780B 20.42
Becton Dickinson (BDX) United States $68.110B 19.27
Cardinal Health (CAH) United States $24.242B 13.86
Align Technology (ALGN) United States $20.454B 39.49
Cooper (COO) United States $18.834B 28.50
Labcorp (LH) United States $17.507B 15.07
Henry Schein (HSIC) United States $9.419B 16.70
DENTSPLY SIRONA (XRAY) United States $5.791B 14.99
Merit Medical Systems (MMSI) United States $4.697B 25.74
Patterson (PDCO) United States $2.267B 10.86
CONMED (CNMD) United States $2.192B 19.88
STAAR Surgical (STAA) United States $2.081B 79.91
Atrion (ATRI) United States $0.784B 41.86
Lifevantage (LFVN) United States $0.085B 10.98
Pro-Dex (PDEX) United States $0.064B 32.09
Biolase (BIOL) United States $0.006B 0.00